Thursday, 7 November 2013

Bayer seeks wider use for eye drug Eylea in Europe

FRANKFURT (Reuters) - German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema. Bayer has said it expects Eylea, also known as VEGF Trap-Eye, to generate more tha...


website view view site view website

No comments:

Post a Comment

Note: only a member of this blog may post a comment.